The global market for cancer pain
therapeutics is expected to post a healthy market growth rate of more than 9% during the forecast period.
Most of the world's population lacks the necessary access to opioids for cancer pain
management and palliative care.
When one considers that effective treatments are cheap and available, untreated cancer pain
and its horrendous consequences for patients and their families is a scandal of global proportions," Cherny says.
Still, the evidence is growing that pain is a multisystemic, multifactorial challenge, felt more acutely in the face of fear or stress, so the wise guidance of those who treat "Dueling Diagnoses" will add value to the treatment of cancer pain
, even in the most straightforward of cases.
Abstral is a rapidly disintegrating tablet for sublingual (under the tongue) administration of fentanyl intended for the management of breakthrough pain in cancer patients who are already receiving opioid analgesics for their underlying persistent cancer pain
The panel urges the public and the health professions to be aware that appropriate pain relief - including narcotics in adequate dosages - is a right of patients with cancer pain
The Pharmacor report entitled Cancer Pain
finds that the product development pipeline for cancer pain
therapies is dominated by potential treatments for severe cancer pain
as most of these drugs are reformulated long-acting opioid analgesics.
The story of Otis' relief from cancer pain
is well documented in a video accessible at www.
Today, the results from a European Survey of Oncology Nurse Breakthrough Cancer Pain
Practices were presented for the first time at The European Multidisciplinary Cancer Congress in Stockholm.
Abstral is a rapidly-disintegrating tablet for sublingual (under the tongue) administration of fentanyl intended for the management of breakthrough pain in cancer patients who are already receiving opioid analgesics for their underlying persistent cancer pain
Abstral is a sublingual (under the tongue) tablet for the fast administration of fentanyl, an opioid commonly used to treat breakthrough cancer pain
in patients who are already receiving opioid analgesics.
Chapters are well arranged into discrete sections pertaining to 1) general considerations, 2) cancer pain
relating to tumour extension, 3) cancer pain
resulting from therapy, 4) multidisciplinary approaches, 5) pharmacological management, 6) non-pharmacological management, 7) interventional techniques and 8) palliative care.